REFERENCES
- Ameisen O. Complete and prolonged suppression of symptoms and conse-quences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol 2005; 40, 147–150.
- Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, et al. Effec-tiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis; randomised, double-blind controlled study. Lancet 2007; 370, 1915–1922.
- Muzyk AJ, Rivelli SK, Gagliardi JP. Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence. CNS Drugs 2012; 26(1), 69–78.
- Rolland B, Bordet R, Cottencin O. Alcohol-dependence: the current French craze for baclofen. Addiction 2012; 107, 848–849.
- Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD001867. DOI: 10.1002/14651858. CD001867. pub3.
- Pettinati HM, Silverman BL, Battisti JJ, Forman R, Schweizer E, Gastfriend DR. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence. Alcoholism clinical and experimental Research 2011; 35(10), 1804–1811.